↓ Skip to main content

Phase II trial evaluating the clinical efficacy of cefixime for treatment of active syphilis in non-pregnant women in Brazil (CeBra)

Overview of attention for article published in BMC Infectious Diseases, June 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase II trial evaluating the clinical efficacy of cefixime for treatment of active syphilis in non-pregnant women in Brazil (CeBra)
Published in
BMC Infectious Diseases, June 2020
DOI 10.1186/s12879-020-04980-1
Pubmed ID
Authors

Melanie M. Taylor, Edna Oliveira Kara, Maria Alix Leite Araujo, Mariangela Freitas Silveira, Angelica Espinosa Miranda, Ivo Castelo Branco Coelho, Maria Luiza Bazzo, Gerson Fernando Mendes Pereira, Silvana Pereira Giozza, Ximena Pamela Díaz Bermudez, Maeve B. Mello, Ndema Habib, My Huong Nguyen, Soe Soe Thwin, Nathalie Broutet

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 56 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 16%
Student > Bachelor 7 13%
Student > Doctoral Student 4 7%
Researcher 4 7%
Student > Ph. D. Student 4 7%
Other 10 18%
Unknown 18 32%
Readers by discipline Count As %
Medicine and Dentistry 15 27%
Nursing and Health Professions 9 16%
Agricultural and Biological Sciences 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Business, Management and Accounting 2 4%
Other 4 7%
Unknown 19 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 June 2020.
All research outputs
#20,622,845
of 23,215,490 outputs
Outputs from BMC Infectious Diseases
#6,570
of 7,784 outputs
Outputs of similar age
#341,258
of 399,052 outputs
Outputs of similar age from BMC Infectious Diseases
#122
of 148 outputs
Altmetric has tracked 23,215,490 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,784 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,052 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 148 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.